Beauty Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Beauty Press Releases.

Press releases published on September 8, 2026

Sep. 8, 2026

Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Emissionsminderungsziele von IPC Systems durch die Science Based Targets Initiative validiert

Indeterminate GlobeNewswire

Sep. 8, 2026

Los objetivos de reducción de emisiones de IPC Systems son validados por la Science Based Targets initiative

Indeterminate GlobeNewswire

Sep. 8, 2026

Science Based Targets Initiative יעדי הפחתת פליטות הפחמן של IPC Systems אומתו בידי

Indeterminate GlobeNewswire

Sep. 8, 2026

IPCシステムズの排出削減目標、科学的知見と整合した目標のイニシアティブによって検証

Indeterminate GlobeNewswire

Sep. 8, 2026

Sasaran Pengurangan Emisi IPC Systems Disahkan oleh Science Based Targets Initiative

Indeterminate GlobeNewswire

Sep. 8, 2026

Metas de Redução de Emissões da IPC Systems Validadas pela Iniciativa de Metas Baseadas na Ciência

Indeterminate GlobeNewswire

Sep. 8, 2026

IPC Systems 的減排目標獲科學基礎目標倡議驗證

Indeterminate GlobeNewswire

Sep. 8, 2026

IPC Systems' Emissions Reduction Targets Validated by the Science Based Targets Initiative

Indeterminate GlobeNewswire

Sep. 8, 2026

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

Indeterminate GlobeNewswire

Sep. 8, 2026

Les objectifs de réduction des émissions d’IPC Systems validés par la Science Based Targets initiative

Indeterminate GlobeNewswire

Sep. 8, 2026

IPC Systems, 온실가스 배출 감축 목표 SBTi 검증 획득

Indeterminate GlobeNewswire

Sep. 8, 2026

IPC Systems 减排目标获得科学碳目标倡议验证

Indeterminate GlobeNewswire

Sep. 8, 2026

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

Indeterminate GlobeNewswire

Sep. 8, 2026

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

Indeterminate GlobeNewswire

Sep. 8, 2026

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

Indeterminate GlobeNewswire

Sep. 8, 2026

MAX Amphibious ATV Returns to The Price Is Right for Star Trek 60th Anniversary Special

Indeterminate GlobeNewswire

Sep. 8, 2026

Phillips Edison & Company to Participate in Webcast Panel at Barclays 24th Annual Financial Services Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire